{"product_id":"biolegend-408101","title":"Biolegend, 408101, Purified anti-phycoerythrin (PE) Antibody, 50μg","description":"\u003cp\u003eThe PE001 antibody reacts with both phycoerythrin (PE) alone and PE conjugated with antibody or streptavidin, as well as PE tandem dyes such as PE\/Cyanine5, PE\/Cyanine5.5 and PE\/Cyanine7. When PE001 antibody is used in a three-step staining procedure or separation of PE-antibody labeled cells, it does not quench PE fluorescence or react with tested mouse and human cells. The PE001 antibody can be used for separation of PE-antibody labeled cells or as a secondary step to amplify PE conjugated primary antibody signals (i.e. biotinylated PE001 as secondary step, followed by Streptavidin-PE).\u003cbr\u003e\n50μg\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Mouse\u003cbr\u003e\nImmunogen: Phycoerythrin\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography.\u003cbr\u003e\nConcentration: 0.5 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C\u003cbr\u003e\nApplication: FC - Quality tested\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. Use at concentrations ≤ 0.5 µg\/test. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Taylor RT, et al. 2007. J. Immunol. 178:5659.\u003cbr\u003e\nProduct Citations: Rouers A, et al. 2021. Cell Rep Med. 2:100278. PubMed Campisi L, et al. 2022. Nature. 606:945. PubMed Donado CA, et al. 2020. Cell Reports. 31(1):107466. PubMed Ma KY, et al. 2021. Nat Immunol. 22:1590. PubMed Dolton G, et al. 2022. Cell. 185:2936. PubMed Kwon M, et al. 2020. Clin Cancer Res. 1644:26. PubMed Leonard JD et al. 2017. Immunity. 47(1):107-117 . PubMed Scur M, et al. 2022. Nat Commun. 13:7272. PubMed Del Alcazar D, et al. 2019. Cell Rep. 28:3047. PubMed Janela B, et al. 2019. Immunity. 50:1069. PubMed Gubin MM, et al. 2018. Cell. 175:1014. PubMed Chng MHY, et al. 2020. Immunity. 51(6):1119-1135.e5.. PubMed Mishra A, et al. 2021. Cell. 184(13):3394-3409.e20. PubMed Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed Rius C, et al. 2018. J Immunol. 200:2263. PubMed Smith CC, et al. 2019. Cancer Immunol Res. 1.396527778. PubMed Sander J et al. 2017. Immunity. 47(6):1051-1066 . PubMed\u003cbr\u003e\nRRID: AB_389236 (BioLegend Cat. No. 408101) AB_2168924 (BioLegend Cat. No. 408102)\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nUniProt: View information about Phycoerythrin on UniProt.org\u003cbr\u003e\nClone: PE001\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: PE\u003cbr\u003e\nIsotype: Mouse IgG1, κ\u003cbr\u003e\nQ: What type of PE do you use in your conjugates?\u003cbr\u003e\nA: We use R-PE in our conjugates.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866161205417,"sku":"408101","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/ar\/products\/biolegend-408101","provider":"Iright","version":"1.0","type":"link"}